Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 14/20 | 0.84 |
| ▸ | ESRRA | P11474 | 2/20 | 0.84 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.57 |
| ▸ | PPARA | Q07869 | 4/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6543673 | 0.99 | PPARG (0.82) | PPARGESRRAFFAR1PPARA | |
| SCHEMBL6543629 | 0.93 | PPARG (0.86) | PPARGESRRAFFAR1PPARA | |
| Hydrochloric Acid SCHEMBL6544755 | 0.93 | PPARG (0.85) | PPARGESRRAFFAR1PPARA | |
| SCHEMBL6543686 | 0.91 | PPARG (0.82) | PPARGESRRAFFAR1PPARA | |
| SCHEMBL6544521 | 0.91 | PPARG (0.75) | PPARGESRRAFFAR1PPARA | |
| Efatutazone SCHEMBL3246054 | 0.91 | PPARG (1.00) | PPARGESRRAFFAR1PPARA | |
| Efatutazone SCHEMBL29379011 | 0.91 | PPARG (1.00) | PPARGESRRAFFAR1PPARA | |
| Hydrochloric Acid SCHEMBL6543621 | 0.90 | PPARG (0.98) | PPARGESRRAFFAR1PPARA | |
| Hydrochloric Acid SCHEMBL6544782 | 0.90 | PPARG (0.74) | PPARGESRRAFFAR1PPARA | |
| Efatutazone SCHEMBL22607936 | 0.90 | PPARG (0.98) | PPARGESRRAFFAR1PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1022272-B1 | SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS | SANKYO CO (JP) | 2004-05-26 | — | — | EP | claimed |
| US-6432993-B1 | BENZIMIDAZOLE OR IMIDAZO(4,5-B)PYRIDINE DERIVATES; IMMUNOMODULATORS; ALDOSE REDUCTASE AND LIPOXYGENASE INHIBITORS; DIABETES; PREVENTS LIPID PEROXIDATION; ANTILIPEMIC, HYPOTENSIVE AGENTS | SANKYO COMPANY, LIMITED (JP) | 2002-08-13 | — | — | US | claimed |
| EP-1022272-A1 | SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS | Sankyo Company Limited (JP) | 2000-07-26 | — | — | EP | claimed |
| EP-1022272-B1 | SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS | SANKYO CO (JP) | 2004-05-26 | — | — | EP | disclosed |
| US-6432993-B1 | BENZIMIDAZOLE OR IMIDAZO(4,5-B)PYRIDINE DERIVATES; IMMUNOMODULATORS; ALDOSE REDUCTASE AND LIPOXYGENASE INHIBITORS; DIABETES; PREVENTS LIPID PEROXIDATION; ANTILIPEMIC, HYPOTENSIVE AGENTS | SANKYO COMPANY, LIMITED (JP) | 2002-08-13 | — | — | US | disclosed |
| EP-1022272-A1 | SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS | Sankyo Company Limited (JP) | 2000-07-26 | — | — | EP | disclosed |